Cargando…

Concordance of in vitro and in vivo measures of non-replicating rotavirus vaccine potency

Rotavirus infections remain a leading cause of morbidity and mortality among infants residing in low- and middle-income countries. To address the large need for protection from this vaccine-preventable disease we are developing a trivalent subunit rotavirus vaccine which is currently being evaluated...

Descripción completa

Detalles Bibliográficos
Autores principales:	McAdams, David, Estrada, Marcus, Holland, David, Singh, Jasneet, Sawant, Nishant, Hickey, John M., Kumar, Prashant, Plikaytis, Brian, Joshi, Sangeeta B., Volkin, David B., Sitrin, Robert, Cryz, Stan, White, Jessica A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405915/ https://www.ncbi.nlm.nih.gov/pubmed/35871866 http://dx.doi.org/10.1016/j.vaccine.2022.07.017

Ejemplares similares

Effect of Aluminum Adjuvant and Preservatives on Structural Integrity and Physicochemical Stability Profiles of Three Recombinant Subunit Rotavirus Vaccine Antigens
por: Agarwal, Sanjeev, et al.
Publicado: (2020)

Characterizing and Minimizing Aggregation and Particle Formation of Three Recombinant Fusion-Protein Bulk Antigens for Use in a Candidate Trivalent Rotavirus Vaccine
por: Agarwal, Sanjeev, et al.
Publicado: (2020)

Recombinant Subunit Rotavirus Trivalent Vaccine Candidate: Physicochemical Comparisons and Stability Evaluations of Three Protein Antigens
por: Agarwal, Sanjeev, et al.
Publicado: (2019)

Quantification of trivalent non-replicating rotavirus vaccine antigens in the presence of aluminum adjuvant
por: McAdams, David, et al.
Publicado: (2021)

Crystallization of a nonreplicating rotavirus vaccine candidate
por: Hong, Moo Sun, et al.
Publicado: (2021)

Rapid Developability Assessments to Formulate Recombinant Protein Antigens as Stable, Low-Cost, Multi-Dose Vaccine Candidates: Case-Study With Non-Replicating Rotavirus (NRRV) Vaccine Antigens
por: Sawant, Nishant, et al.
Publicado: (2021)

Mechanism of Thimerosal-Induced Structural Destabilization of a Recombinant Rotavirus P[4] Protein Antigen Formulated as a Multi-Dose Vaccine
por: Kaur, Kawaljit, et al.
Publicado: (2021)

Current and next-generation formulation strategies for inactivated polio vaccines to lower costs, increase coverage, and facilitate polio eradication
por: Kumar, Prashant, et al.
Publicado: (2022)

Holistic process development to mitigate proteolysis of a subunit rotavirus vaccine candidate produced in Pichia pastoris by means of an acid pH pulse during fed‐batch fermentation
por: Velez‐Suberbie, M. Lourdes, et al.
Publicado: (2020)

Formulation development of a live attenuated human rotavirus (RV3-BB) vaccine candidate for use in low- and middle-income countries
por: Kumar, Prashant, et al.
Publicado: (2021)

Effect of Formulation Variables on the Stability of a Live, Rotavirus (RV3-BB) Vaccine Candidate using in vitro Gastric Digestion Models to Mimic Oral Delivery
por: Kumar, Prashant, et al.
Publicado: (2021)

Developing a manufacturing process to deliver a cost effective and stable liquid human rotavirus vaccine
por: Hamidi, Ahd, et al.
Publicado: (2021)

Correlating physicochemical and biological properties to define critical quality attributes of a rAAV vaccine candidate
por: Kumar, Prashant, et al.
Publicado: (2023)

Development of Stabilizing Formulations of a Trivalent Inactivated Poliovirus Vaccine in a Dried State for Delivery in the Nanopatch™ Microprojection Array
por: Wan, Ying, et al.
Publicado: (2018)

Development of a candidate stabilizing formulation for bulk storage of a double mutant heat labile toxin (dmLT) protein based adjuvant
por: Toprani, Vishal M., et al.
Publicado: (2017)

A C-terminal Pfs48/45 malaria transmission-blocking vaccine candidate produced in the baculovirus expression system
por: Lee, Shwu-Maan, et al.
Publicado: (2020)

Developability Assessment of Physicochemical Properties and Stability Profiles of HIV-1 BG505 SOSIP.664 and BG505 SOSIP.v4.1-GT1.1 gp140 Envelope Glycoprotein Trimers as Candidate Vaccine Antigens
por: Whitaker, Neal, et al.
Publicado: (2019)

Molecular engineering improves antigen quality and enables integrated manufacturing of a trivalent subunit vaccine candidate for rotavirus
por: Dalvie, Neil C., et al.
Publicado: (2021)

Nanoscale organization of rotavirus replication machineries
por: Garcés Suárez, Yasel, et al.
Publicado: (2019)

Structural Characterization and Physicochemical Stability Profile of a Double Mutant Heat Labile Toxin Protein Based Adjuvant
por: Toprani, Vishal M., et al.
Publicado: (2017)

Formulation development and comparability studies with an aluminum-salt adjuvanted SARS-CoV-2 Spike ferritin nanoparticle vaccine antigen produced from two different cell lines
por: Kumru, Ozan S., et al.
Publicado: (2023)

Coformulation of Broadly Neutralizing Antibodies 3BNC117 and PGT121: Analytical Challenges During Preformulation Characterization and Storage Stability Studies
por: Patel, Ashaben, et al.
Publicado: (2018)

Preformulation Characterization and Stability Assessments of Secretory IgA Monoclonal Antibodies as Potential Candidates for Passive Immunization by Oral Administration
por: Hu, Yue, et al.
Publicado: (2020)

The Pfs230 N-terminal fragment, Pfs230D1+: expression and characterization of a potential malaria transmission-blocking vaccine candidate
por: Lee, Shwu-Maan, et al.
Publicado: (2019)

Molecular Biology of Rotavirus Entry and Replication
por: Ruiz, Marie Christine, et al.
Publicado: (2009)

Measurement of Adenovirus-Based Vector Heterogeneity
por: Hickey, John M., et al.
Publicado: (2023)

Association between Immunogenicity of a Monovalent Parenteral P2-VP8 Subunit Rotavirus Vaccine and Fecal Shedding of Rotavirus following Rotarix Challenge during a Randomized, Double-Blind, Placebo-Controlled Trial
por: Fellows, Tamika, et al.
Publicado: (2023)

Formulation and preclinical studies with a trivalent rotavirus P2-VP8 subunit vaccine
por: Lakatos, Kyle, et al.
Publicado: (2020)

Rotavirus genome replication: Some assembly required
por: Long, Courtney P., et al.
Publicado: (2017)

Viroplasms: Assembly and Functions of Rotavirus Replication Factories
por: Papa, Guido, et al.
Publicado: (2021)

Rotavirus Replication in the Cholangiocyte Mediates the Temporal Dependence of Murine Biliary Atresia
por: Mohanty, Sujit K., et al.
Publicado: (2013)

Formulation Development and Improved Stability of a Combination Measles and Rubella Live-Viral Vaccine Dried for Use in the Nanopatch(TM) Microneedle Delivery System
por: Wan, Ying, et al.
Publicado: (2021)

Rotavirus NSP1 Contributes to Intestinal Viral Replication, Pathogenesis, and Transmission
por: Hou, Gaopeng, et al.
Publicado: (2021)

Electron microscopic analysis of rotavirus assembly-replication intermediates
por: Boudreaux, Crystal E., et al.
Publicado: (2015)

Short-term and longer-term protective immune responses generated by subunit vaccination with smallpox A33, B5, L1 or A27 proteins adjuvanted with aluminum hydroxide and CpG in mice challenged with vaccinia virus
por: Xiao, Yuhong, et al.
Publicado: (2020)

Relative potency estimation for synthetic petroleum skin carcinogens.
por: Holland, J M, et al.
Publicado: (1981)

Rotavirus vaccine efficacy up to 2 years of age and against diverse circulating rotavirus strains in Niger: Extended follow-up of a randomized controlled trial
por: Isanaka, Sheila, et al.
Publicado: (2021)

18β-glycyrrhetinic acid inhibits rotavirus replication in culture
por: Hardy, Michele E, et al.
Publicado: (2012)

The actin cytoskeleton is important for rotavirus internalization and RNA genome replication
por: Trejo-Cerro, Oscar, et al.
Publicado: (2019)

Rotavirus-Induced Lipid Droplet Biogenesis Is Critical for Virus Replication
por: Criglar, Jeanette M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1hhr0p7nnejjktv4spmv6b4aej